Advances in infectious diseases

In : Recent Advances in Canine Infectious Diseases

In : Recent Advances in Canine Infectious Diseases

Introduction The etiologic agent of canine monocytic ehrlichiosis (CME), the rickettsia Ehrlichia canis (E. canis), is a small pleomorphic gram-negative coccoid bacteria that parasitizes circulating monocytes intracytoplasmically in clusters of organisms called morulae. The disease is also known as canine rickettsiosis, canine hemorrhagic fever, tracker dog disease, canine tick typhus, Nairobi ...

Advances in Emerging and Neglected Infectious Diseases

Emerging and neglected infections have proven to be highly lethal with mortality rates ranging from 10 to 80%. However, with a low incidence of disease, less public attention and support have been directed at these infections. Much more research is devoted to infections with a large public health impact, neglecting these potential diseases. Nonetheless, there are numerous infectious diseases wa...

Corticosteroids in Infectious Diseases

Accumulated data based on experiences with curtico,teroids in the management uf infectious disea­ses, have proved that they are very dfective and ,afe drugs provided that are administered properly.  The Corticosteroids arc administered mainly be­c,1usc o; antitoxic, antiimflammatory a11d antiallcrgic effects, the cndotoxius are ncuturalized, generalized body reactions are diminished, damaged t...

Advances and challenges in biosensor-based diagnosis of infectious diseases.

Rapid diagnosis of infectious diseases and timely initiation of appropriate treatment are critical determinants that promote optimal clinical outcomes and general public health. Conventional in vitro diagnostics for infectious diseases are time-consuming and require centralized laboratories, experienced personnel and bulky equipment. Recent advances in biosensor technologies have potential to d...